Renal tubulointerstitial lesions: a prognostic marker in idiopathic membranous nephropathy

Renal tubulointerstitial lesions: a prognostic marker in idiopathic membranous nephropathy

Objective To evaluate the impact of renal tubulointerstitial lesions (TIL) on clinical and pathologic outcomes and prognosis in patients with idiopathic membranous nephropathy.Methods A retrospective cohort study was performed on 582 patients with idiopathic membranous nephropathy. Patients were div...

Full description

Saved in:

Bibliographic Details
Main Authors:	Yonghua Liu, Xiuhua Ma, Min Yu, Xiaoling Zhou
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2025-12-01
Series:	Renal Failure
Subjects:	Idiopathic membranous nephropathy renal tubulointerstitial lesions clinicopathological prognosis
Online Access:	https://www.tandfonline.com/doi/10.1080/0886022X.2025.2501379
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Clinical characteristics and prognosis of patients with idiopathic membranous nephropathy with kidney tubulointerstitial damage
by: Mengyao Sun, et al.
Published: (2023-12-01)

Renal arteriolosclerosis impact on clinicopathological features and outcomes of idiopathic membranous nephropathy: a retrospective cohort analysis
by: Rui Jiang, et al.
Published: (2025-05-01)

Clinicopathological analysis of idiopathic membranous nephropathy in different age groups
by: CAI Juan-juan, et al.
Published: (2015-01-01)

Effects of smoking on renal function and pathological changes in idiopathic membranous nephropathy (IMN) patients
by: LUAN Ru-mei, et al.
Published: (2020-01-01)

Glucocorticoid does not improve the renal prognosis of patients with diabetic nephropathy combined with acute tubulointerstitial nephritis: a retrospective analysis
by: Jingwei Tian, et al.
Published: (2024-12-01)

Correlation of renal pathological changes with survival and prognosis in patients with diabetic nephropathy
by: TAN Xiao-yan, et al.
Published: (2019-01-01)

Clinical efficacy of tacrolimus combined with glucocorticoids for idiopathic membranous nephropathy
by: LING Yi-sheng, et al.
Published: (2016-01-01)

Factors promoting development of renal tubulointerstitial lesions in patients with diabetes mellitus
by: Minara Shamkhalovna Shamkhalova, et al.
Published: (2010-09-01)

Clinical significance of renal IgM deposition in adult idiopathic membranous nephropathy
by: SUN Yan-jie, et al.
Published: (2018-01-01)

A retrospective study of calcineurin inhibitors in the treatment of idiopathic membranous nephropathy
by: CUI Lin-lin, et al.
Published: (2015-01-01)

Research advances of idiopathic membranous nephropathy with non-nephrotic range proteinuria
by: Sun Jing, et al.
Published: (2022-10-01)

Analysis of related factors of clinical and renal pathological characteristics in patients with idiopathic membranous nephropathy
by: GUO Guang-feng, et al.
Published: (2020-01-01)

Clinicopathological and prognostic study of idiopathic membranous nephropathy with tip or non-tip variant focal segmental glomerulosclerosis: a single-center cohort study
by: Shungang Xu, et al.
Published: (2025-12-01)

Clinical analysis of low-dos erituximab in the treatment of refractory idiopathic membranous nephropathy
by: Yuan Zhong-fei, et al.
Published: (2021-01-01)

A controlled clinical study of efficacy of different treatment regimens for idiopathic membranous nephropathy
by: LUO Man-yu, et al.
Published: (2019-01-01)

Effect of losartan on urinary protein spectrum in patients with idiopathic membranous nephropathy
by: PAN Jing-nian, et al.
Published: (2015-01-01)

Clinical and pathological features of idiopathic membranous nephropathy patients combined with hyperuricemia
by: ZHAO Li, et al.
Published: (2017-01-01)

Clinical observation of responses to two plasma concentrations of tacrolimus in treatment of idiopathic membranous nephropathy stage Ⅱ
by: LI Xiao-yong
Published: (2019-01-01)

Bioinformatics analysis of potential key ferroptosis-related genes involved in tubulointerstitial injury in patients with diabetic nephropathy
by: Li-Li Ma, et al.
Published: (2023-12-01)

Correlation of Body Mass Index with Clinicopathologic Parameters in Patients with Idiopathic Membranous Nephropathy [Corrigendum]
by: Chen X, et al.
Published: (2025-08-01)

Association of serum homocysteine levels with acute kidney injury in patients with idiopathic membranous nephropathy
by: XIE Yi-yi, et al.
Published: (2018-01-01)

Clinical observation of low-dose cyclosporine A combined with small dose of hormone in the treatment of idiopathic membranous nephropathy
by: ZHANG Jian, et al.
Published: (2017-01-01)

Efficacy of tacrolimus or cyclophosphamide combined with glucocorticoids in the treatment of idiopathic membranous nephropathy
by: MAO Wen-li, et al.
Published: (2018-01-01)

Idiopathic membranous nephropathy with focal segmental sclerosis
by: Elena S. Kamyshova, et al.
Published: (2024-01-01)

A single-center retrospective study of ectopic lymphoid tissues in idiopathic membranous nephropathy: clinical pathological characteristics and prognostic value
by: Jing Zhang, et al.
Published: (2024-12-01)

The efficacy and safety of ripertamab in the treatment of idiopathic membranous nephropathy: a retrospective multicenter cohort study
by: Xinyang Li, et al.
Published: (2025-07-01)

Correlation analysis of serum IgG with clinicopathological features and prognosis of patients with idiopathic membranous nephropathy
by: LI Xian, et al.
Published: (2025-02-01)

Acute kidney injury in patients with idiopathic membranous nephropathy: influencing factors and prognosis
by: Zhenzhou Li, et al.
Published: (2023-12-01)

Screening potential diagnostic biomarkers for PLA2R‑associated idiopathic membranous nephropathy by WGCNA analysis and LASSO algorithm
by: Jinxu Huang, et al.
Published: (2025-12-01)

Clinicopathological features and outcome in elderly patients with idiopathic membranous nephropathy
by: Jinxiu Liang, et al.
Published: (2023-12-01)

A mono-center clinical study on clinical pathological features and prognosis of adult idiopathic membranous nephropathy
by: CHEN Jing, et al.
Published: (2019-01-01)

Clinicopathological characteristics of idiopathic membranous nephropathy in 65 elderly patients
by: LIU Wen-xue, et al.
Published: (2017-01-01)

Meta-analysis of efficacy and safety of multi-glycoside of Tripterygium wilfordii in the treatment of idiopathic membranous nephropathy
by: YIN Song-jiang, et al.
Published: (2016-01-01)

The research progress of thrombospondin type-1 domain 7A and its antibodies in idiopathic membranous nephropathy
by: LI Jun, et al.
Published: (2019-01-01)

Factors of tubulointerstitial lesions in diabetic kidneys
by: Minara Shamkhalovna Shamkhalova, et al.
Published: (2009-12-01)

JiangyaTongluo decoction ameliorates tubulointerstitial fibrosis via regulating the SIRT1/PGC-1α/mitophagy axis in hypertensive nephropathy
by: Yun Zhao, et al.
Published: (2024-12-01)

Effectiveness and safety of immunosuppressive regimens for adult idiopathic membranous nephropathy: network Meta-analysis
by: Zhou Ye-na, et al.
Published: (2021-01-01)

Serumanti-PLA2R antibody predicted treatment outcome in idiopathic membranous nephropathy
by: Zhang Xue-qin, et al.
Published: (2021-01-01)

ASSESMENT TUBULOINTERSTITIAL CHANGES IN THE RENAL PARENCHYMA IN THE SURGICAL TREATMENT OF NEPHROLITHIASIS
by: G. N. Maslyakova, et al.
Published: (2014-03-01)

Telitacicept monotherapy for refractory idiopathic membranous nephropathy: a case report and literature review
by: Shucheng Chen, et al.
Published: (2025-04-01)